Overview

Neoadjuvant Chemotherapy Followed by Chemoradiation Versus Chemoradiation for Stage IIIC Cervical Cancer Patients: A Randomized Phase III Trial

Status:
Recruiting

Trial end date:
2027-03-31

Target enrollment:

Participant gender:

Summary

Evaluate the efficacy and safety of neoadjuvant chemotherapy (NAC) with albumin-bound paclitaxel and carboplatin followed by chemoradiation therapy (CRT) for stage IIIC cervical cancer patients with carcinoma >4 cm in greatest dimension and/or lymph node >2cm in short axis.

Phase:

Phase 3

Details

Lead Sponsor:

Sun Yat-sen University

Treatments:

Albumin-Bound Paclitaxel
Carboplatin
Paclitaxel